nov-002 has been researched along with Postoperative-Complications* in 2 studies
1 trial(s) available for nov-002 and Postoperative-Complications
| Article | Year |
|---|---|
[Glutoxim in the surgical treatment of patients with pulmonary tuberculosis].
Surgery results in the development of secondary immunodeficiency associated with inhibition of the phagocytic bactericidal systems, leading to postoperative complications. Glutoxim, a representative of thiopoietins, was used to reduce the number of postoperative complications. Twenty-nine patients with pulmonary tuberculosis received glutoxim therapy (a study group). A control group comprised 25 patients. A course of glutoxim therapy was 35 days; the daily dose was 60 mg. Postoperative complications (tuberculous pleural empyema with bronchopleural fistula, progressive tuberculosis, nonspecific pneumonias) developed in 2 (6.9%) study group patients and in 8 (32%) control ones (p < 0.05). The inclusion ofglutoxim into complex preoperative preparation and its postoperative use cause a significant reduction in postoperative complications. Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oligopeptides; Postoperative Complications; Preoperative Care; Tuberculosis, Pulmonary | 2007 |
1 other study(ies) available for nov-002 and Postoperative-Complications
| Article | Year |
|---|---|
[Efficacy of application of thiopoietines in complex of treatment of an acute adhesive ileus in patients with hepatic function disorder].
The peculiarities of an acute adhesive ileus (AAI) course in patients, suffering hepatic function disorder (HFD), were studied up, the additions to the conservative treatment scheme were proposed. There was established, that while HFD presence in the patients the trustworthy enhanced recurrence rate of adhesive disease is observed after operations, performed for AAM, The adhesive disease recurrence rate do not depend on the surgical access kind. Application of preparations, related to thiopoietins group and hepatoprotectors, while AAI treatment conduction, have promoted reduction of the peritoneal adhesive disease recurrence rate in terms of the three years postoperative follow-up. Topics: Acute Disease; Digestive System Surgical Procedures; Drug Administration Schedule; Female; Follow-Up Studies; Hepatic Insufficiency; Humans; Ileus; Laparoscopy; Male; Oligopeptides; Phosphatidylcholines; Postoperative Complications; Secondary Prevention | 2012 |